Skip to main content
Clinical Trials/TCTR20210413001
TCTR20210413001
Not Yet Recruiting
Phase 2

asal High Flow Oxygen Versus Non Invasive Positive Pressure Ventilation in Emergency Department Patients With Cardiogenic Pulmonary Edema: A Randomized Non-inferiority Trial

Siriraj Research and Development Fund0 sites240 target enrollmentApril 13, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
acute cardiogenic pulmonary edema
Sponsor
Siriraj Research and Development Fund
Enrollment
240
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 13, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Siriraj Research and Development Fund

Eligibility Criteria

Inclusion Criteria

  • 1\.Adult patients (18 years of age and above) presenting with ACPE diagnosed by the attending ED physician by meeting all of the following criteria
  • \-History of acute dyspnea
  • \-Bilateral rales on physical examination
  • \-At least one of the following signs on the initial chest radiograph: pulmonary venous congestion, cardiomegaly, and interstitial edema
  • 2\.Significant respiratory distress in need for non\-invasive respiratory support measures by meeting all of the following
  • \-Respiratory rate (RR) \> 24 breaths/min
  • \-Pulse oximetry (SpO2\) \< 92% when breathing at room air or arterial pressure of oxygen (PaO2\)/fraction of inspired oxygen (FiO2\) \< 300 or SpO2/FiO2 \< 240
  • \-Signs of respiratory distress, e.g., accessory muscle use

Exclusion Criteria

  • 1\.Respiratory failure needing immediate endotracheal intubation, defined as RR \> 35 breaths/min, SpO2 \< 90% despite oxygen supplement at FiO2\= 1\.0, or abdominal dyssynchrony
  • 2\.Patients with cardiac or respiratory arrest
  • 3\.Patients with hemodynamic instability, defined as systolic blood pressure \< 90 mmHg or mean arterial pressure \< 65 mmHg with signs of poor tissue perfusion
  • 4\.Patients with altered mental status, defined as a Glasgow Coma Scale (GCS) score \< 13
  • 5\.Agitated or non\-cooperative patients
  • 6\.Patients contraindicated to the use of NIPPV and HFNC, i.e. at risk for aspiration, known or suspected pneumothorax
  • 7\.Patients with chronic kidney disease stage V or end\-stage renal disease
  • 8\.Patients with ST\-segment elevation myocardial infarction
  • 9\.Patients with do\-not\-intubate order
  • 10\.Patients with long\-term non\-invasive or invasive respiratory support

Outcomes

Primary Outcomes

Not specified

Similar Trials